242 related articles for article (PubMed ID: 34228644)
1. Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma.
Chen A; Jiang Y; Li Z; Wu L; Santiago U; Zou H; Cai C; Sharma V; Guan Y; McCarl LH; Ma J; Wu YL; Michel J; Shi Y; Konnikova L; Amankulor NM; Zinn PO; Kohanbash G; Agnihotri S; Lu S; Lu X; Sun D; Gittes GK; Wang Q; Xiao X; Yimlamai D; Pollack IF; Camacho CJ; Hu B
J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34228644
[No Abstract] [Full Text] [Related]
2. SLIT2/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia.
Geraldo LH; Xu Y; Jacob L; Pibouin-Fragner L; Rao R; Maissa N; Verreault M; Lemaire N; Knosp C; Lesaffre C; Daubon T; Dejaegher J; Solie L; Rudewicz J; Viel T; Tavitian B; De Vleeschouwer S; Sanson M; Bikfalvi A; Idbaih A; Lu QR; Lima FR; Thomas JL; Eichmann A; Mathivet T
J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34181595
[TBL] [Abstract][Full Text] [Related]
3. Macrophages/Microglia in the Glioblastoma Tumor Microenvironment.
Ma J; Chen CC; Li M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071306
[TBL] [Abstract][Full Text] [Related]
4. TLR4 expression and functionality are downregulated in glioblastoma cells and in tumor-associated macrophages: A new mechanism of immune evasion?
da Cruz LLP; de Souza PO; Dal Prá M; Falchetti M; de Abreu AM; Azambuja JH; Bertoni APS; Paz AHR; Araújo AB; Visioli F; Fazolo T; da Silva GG; Worm PV; Wink MR; Zanotto-Filho A; Braganhol E
Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166155. PubMed ID: 33932524
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth.
Rivera-Ramos A; Cruz-Hernández L; Talaverón R; Sánchez-Montero MT; García-Revilla J; Mulero-Acevedo M; Deierborg T; Venero JL; Sarmiento Soto M
Cancer Lett; 2024 Jun; 591():216879. PubMed ID: 38636895
[TBL] [Abstract][Full Text] [Related]
6. Local Targeting of NAD
Li M; Kirtane AR; Kiyokawa J; Nagashima H; Lopes A; Tirmizi ZA; Lee CK; Traverso G; Cahill DP; Wakimoto H
Cancer Res; 2020 Nov; 80(22):5024-5034. PubMed ID: 32998997
[TBL] [Abstract][Full Text] [Related]
7. MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas.
Wang QW; Sun LH; Zhang Y; Wang Z; Zhao Z; Wang ZL; Wang KY; Li GZ; Xu JB; Ren CY; Ma WP; Wang HJ; Li SW; Zhu YJ; Jiang T; Bao ZS
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34667077
[TBL] [Abstract][Full Text] [Related]
8. The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy.
Yeo ECF; Brown MP; Gargett T; Ebert LM
Cells; 2021 Mar; 10(3):. PubMed ID: 33803414
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma-activated pericytes support tumor growth via immunosuppression.
Sena IFG; Paiva AE; Prazeres PHDM; Azevedo PO; Lousado L; Bhutia SK; Salmina AB; Mintz A; Birbrair A
Cancer Med; 2018 Apr; 7(4):1232-1239. PubMed ID: 29479841
[TBL] [Abstract][Full Text] [Related]
10. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
11. Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis.
Cui X; Morales RT; Qian W; Wang H; Gagner JP; Dolgalev I; Placantonakis D; Zagzag D; Cimmino L; Snuderl M; Lam RHW; Chen W
Biomaterials; 2018 Apr; 161():164-178. PubMed ID: 29421553
[TBL] [Abstract][Full Text] [Related]
12. Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies.
Pombo Antunes AR; Scheyltjens I; Duerinck J; Neyns B; Movahedi K; Van Ginderachter JA
Elife; 2020 Feb; 9():. PubMed ID: 32014107
[TBL] [Abstract][Full Text] [Related]
13. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.
Wei J; Wang F; Kong LY; Xu S; Doucette T; Ferguson SD; Yang Y; McEnery K; Jethwa K; Gjyshi O; Qiao W; Levine NB; Lang FF; Rao G; Fuller GN; Calin GA; Heimberger AB
Cancer Res; 2013 Jul; 73(13):3913-26. PubMed ID: 23636127
[TBL] [Abstract][Full Text] [Related]
14. Harnessing the immune system in glioblastoma.
Brown NF; Carter TJ; Ottaviani D; Mulholland P
Br J Cancer; 2018 Nov; 119(10):1171-1181. PubMed ID: 30393372
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Assay to Study Tumor-macrophage Interaction.
An Z; Weiss WA
J Vis Exp; 2019 Aug; (150):. PubMed ID: 31424440
[TBL] [Abstract][Full Text] [Related]
16. The role of STAT3 in tumor-mediated immune suppression.
Ferguson SD; Srinivasan VM; Heimberger AB
J Neurooncol; 2015 Jul; 123(3):385-94. PubMed ID: 25700834
[TBL] [Abstract][Full Text] [Related]
17. Microglia-Centered Combinatorial Strategies Against Glioblastoma.
Martins TA; Schmassmann P; Shekarian T; Boulay JL; Ritz MF; Zanganeh S; Vom Berg J; Hutter G
Front Immunol; 2020; 11():571951. PubMed ID: 33117364
[TBL] [Abstract][Full Text] [Related]
18. Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types.
Khalsa JK; Cheng N; Keegan J; Chaudry A; Driver J; Bi WL; Lederer J; Shah K
Nat Commun; 2020 Aug; 11(1):3912. PubMed ID: 32764562
[TBL] [Abstract][Full Text] [Related]
19. Immune Microenvironment in Glioblastoma Subtypes.
Chen Z; Hambardzumyan D
Front Immunol; 2018; 9():1004. PubMed ID: 29867979
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma Immune Landscape and the Potential of New Immunotherapies.
Daubon T; Hemadou A; Romero Garmendia I; Saleh M
Front Immunol; 2020; 11():585616. PubMed ID: 33154756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
